388 related articles for article (PubMed ID: 8677452)
21. Ifosfamide, carboplatin, etoposide, and paclitaxel chemotherapy: a dose-escalation study.
Chang AY; Boros L; Garrow GC; Asbury RF; Hui L
Semin Oncol; 1996 Jun; 23(3 Suppl 6):74-7. PubMed ID: 8677454
[TBL] [Abstract][Full Text] [Related]
22. Ifosfamide- and cisplatin-containing chemotherapy as first-line salvage therapy in germ cell tumors: response and survival.
McCaffrey JA; Mazumdar M; Bajorin DF; Bosl GJ; Vlamis V; Motzer RJ
J Clin Oncol; 1997 Jul; 15(7):2559-63. PubMed ID: 9215825
[TBL] [Abstract][Full Text] [Related]
23. Ifosfamide in testicular cancer: the Indiana University experience.
Loehrer PJ; Williams SD; Einhorn LH
Semin Oncol; 1989 Feb; 16(1 Suppl 3):96-101. PubMed ID: 2539649
[TBL] [Abstract][Full Text] [Related]
24. Lomustine (chloroethylnitrosourea [CCNU]), ifosfamide, bleomycin, vincristine, and cisplatin (CIBO-P) is an effective regimen for patients with poor prognostic refractory or multiple disease recurrent aggressive non-Hodgkin lymphoma.
Musolino A; Perrone MA; Michiara M; Delnevo D; Franciosi V; Di Blasio B; Ceci G; Camisa R; Ardizzoni A; Cocconi G
Cancer; 2005 May; 103(10):2109-17. PubMed ID: 15803492
[TBL] [Abstract][Full Text] [Related]
25. Chemotherapy in patients with metastatic or relapsed germ-cell tumours.
Rick O; Siegert W; Beyer J
Cancer Treat Rev; 2001 Oct; 27(5):283-8. PubMed ID: 11871864
[TBL] [Abstract][Full Text] [Related]
26. Salvage therapy for germ cell tumors.
Einhorn LH
Semin Oncol; 1994 Aug; 21(4 Suppl 7):47-51. PubMed ID: 8091241
[TBL] [Abstract][Full Text] [Related]
27. Refining therapeutic strategies for patients with resistant Wilm's tumor.
Marina NM; Wilimas JA; Meyer WH; Jones DP; Douglass EC; Pratt CB
Am J Pediatr Hematol Oncol; 1994 Nov; 16(4):296-300. PubMed ID: 7978044
[TBL] [Abstract][Full Text] [Related]
28. [Salvage therapy for refractory testicular cancer].
Kawai K; Akaza H
Gan To Kagaku Ryoho; 1996 Aug; 23(9):1129-35. PubMed ID: 8751799
[TBL] [Abstract][Full Text] [Related]
29. Phase I/II study of sequential dose-intensified ifosfamide, cisplatin, and etoposide plus paclitaxel as induction chemotherapy for poor prognosis germ cell tumors by the German Testicular Cancer Study Group.
Hartmann JT; Gauler T; Metzner B; Gerl A; Casper J; Rick O; Horger M; Schleicher J; Derigs G; Mayer-Steinacker R; Beyer J; Kuczyk MA; Bokemeyer C;
J Clin Oncol; 2007 Dec; 25(36):5742-7. PubMed ID: 18089869
[TBL] [Abstract][Full Text] [Related]
30. High-dose chemotherapy for salvage treatment of germ cell tumors: Charité, Virchow Klinikum, Berlin.
Siegert W; Rick O; Beyer J
Bone Marrow Transplant; 1998 Dec; 22 Suppl 4():S7-9. PubMed ID: 9916622
[No Abstract] [Full Text] [Related]
31. Poor-risk testicular cancer and high-dose chemotherapy.
Motzer RJ; Sheinfeld S
J Clin Oncol; 2003 Nov; 21(22):4073-4. PubMed ID: 14568986
[No Abstract] [Full Text] [Related]
32. [A case of recurrent metastatic testicular cancer, successfully treated with paclitaxel, ifomide and cisplatin].
Yanada S; Ito H; Tomita M; Wada T; Hatano T; Kishimoto K; Egawa S
Hinyokika Kiyo; 2008 Jan; 54(1):43-6. PubMed ID: 18260360
[TBL] [Abstract][Full Text] [Related]
33. Analysis of dose-response relationships in the setting of high-dose ifosfamide, carboplatin, and etoposide and autologous hematopoietic stem cell transplantation: implications for the treatment of patients with advanced breast cancer.
Perkins JB; Effenbein GJ; Fields KK
Semin Oncol; 1996 Jun; 23(3 Suppl 6):42-6. PubMed ID: 8677448
[TBL] [Abstract][Full Text] [Related]
34. Metastatic seminoma treated with either single agent carboplatin or cisplatin-based combination chemotherapy: a pooled analysis of two randomised trials.
Bokemeyer C; Kollmannsberger C; Stenning S; Hartmann JT; Horwich A; Clemm C; Gerl A; Meisner C; Rückerl CP; Schmoll HJ; Kanz L; Oliver T
Br J Cancer; 2004 Aug; 91(4):683-7. PubMed ID: 15266338
[TBL] [Abstract][Full Text] [Related]
35. Chemotherapy for good-risk germ-cell tumors.
Ryan CJ; Bajorin DF
Semin Urol Oncol; 2002 Nov; 20(4):244-50. PubMed ID: 12489057
[TBL] [Abstract][Full Text] [Related]
36. Single versus sequential high-dose chemotherapy in patients with relapsed or refractory germ cell tumors: a prospective randomized multicenter trial of the German Testicular Cancer Study Group.
Lorch A; Kollmannsberger C; Hartmann JT; Metzner B; Schmidt-Wolf IG; Berdel WE; Weissinger F; Schleicher J; Egerer G; Haas A; Schirren R; Beyer J; Bokemeyer C; Rick O;
J Clin Oncol; 2007 Jul; 25(19):2778-84. PubMed ID: 17602082
[TBL] [Abstract][Full Text] [Related]
37. [Treatment of advanced testicular cancer and toxicity of chemotherapy].
Kawakita M; Matsuda T; Terachi T; Yoshida O
Hinyokika Kiyo; 1999 Nov; 45(11):783-6. PubMed ID: 10637744
[TBL] [Abstract][Full Text] [Related]
38. A threefold dose intensity treatment with ifosfamide, carboplatin, and etoposide for patients with small cell lung cancer: a randomized trial.
Leyvraz S; Pampallona S; Martinelli G; Ploner F; Perey L; Aversa S; Peters S; Brunsvig P; Montes A; Lange A; Yilmaz U; Rosti G;
J Natl Cancer Inst; 2008 Apr; 100(8):533-41. PubMed ID: 18398095
[TBL] [Abstract][Full Text] [Related]
39. [Is still there an indication for high-dose chemotherapy with hematopoietic stem-cell support in the treatment of germ-cell tumors?].
Fléchon A; Droz JP
Bull Cancer; 2001 Sep; 88(9):852-7. PubMed ID: 11604357
[TBL] [Abstract][Full Text] [Related]
40. Incidence of late-relapse germ cell tumor and outcome to salvage chemotherapy.
Ronnen EA; Kondagunta GV; Bacik J; Marion S; Bajorin DF; Sheinfeld J; Bosl GJ; Motzer RJ
J Clin Oncol; 2005 Oct; 23(28):6999-7004. PubMed ID: 16192587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
